HUNTSVILLE, AL, July 29, 2025 (GLOBE NEWSWIRE) -- Serina Therapeutics, Inc. (SER), a clinical-stage biotechnology company developing its proprietary POZ Platform ™ drug optimization technology, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results